Last week the United States Preventive Services Task Force (USPSTF) released its fifth report to Congress highlighting women’s health as a high priority gap in clinical preventative services. Recognizing the reproductive and biologic differences in women, as well as such external factors as home and work environments and economic and educational resources, the USPSTF has … Continued
November 18, 2015 Contact: Lisa Mauti lmauti@ovariancancer.org Public health evidence points to need for FDA regulation of laboratory developed tests “The consequences of inaccurate test results, such as false positives, can result in the unnecessary removal of a woman’s ovaries. It is critical that patients know their test results can be trusted.” Washington, DC — … Continued
Washington, DC — On November 17th, the Food and Drug Administration (FDA) released a report: The Public Health Evidence for FDA Oversight of Laboratory Developed Tests: 20 Case Studies, that outlines the harm that not regulating laboratory developed tests (LDTs) can cause to patients and to the economy. Included in the report were two case studies about … Continued
For Immediate ReleaseSeptember 23, 2015 New Ovarian Cancer National Alliance research finds state lawmakers have power to dramatically improve access to ovarian cancer care and outcomes for the 21,000 women diagnosed each year WASHINGTON, D.C. — Today, the Ovarian Cancer National Alliance (OCNA) released groundbreaking new data in its report “50 States of Teal: Ovarian … Continued
For Immediate ReleaseSeptember 28, 2015 Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday WASHINGTON, D.C. — Tomorrow, Representatives Sean Duffy and Rosa DeLauro, who have each been … Continued
In January’s State of the Union Address, President Obama ushered in an exciting phase in new medical research by introducing the Precision Medicine Initiative (PMI). This initiative will expand our understanding of personalized medicine, when doctors pick treatments to suit individual patients rather than the ‘one-size-fits-all’ approach. Since January, the President’s advisers have begun to … Continued
By Annie Ellis: On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Click plus sign to read more.
By Annie Ellis On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the … Continued
MEDIA ADVISORY September 10, 2015 Contact: Lisa Mauti (lmauti@ovariancancer.org, 443-845-2626) MEDIA ADVISORY: Where women live impacts health: New report reveals unequal access to ovarian cancer care Ovarian Cancer National Alliance says state lawmakers can make changes that would improve care for the more than 21,000 women diagnosed each year WASHINGTON, D.C. — New findings reveal … Continued
FOR IMMEDIATE RELEASESeptember 2, 2015 Sherry Pollex and the Ovarian Cancer National Alliance launch “The TealAppeal” to raise ovarian cancer awarenessPollex, Ovarian Cancer National Alliance, Martin Truex Jr., and Danica Patrickjoin forces during September’s National Ovarian Cancer Awareness Month, tosave more women’s lives DARLINGTON, SC — On Sunday, Sherry Pollex and the Ovarian Cancer National … Continued
FOR IMMEDIATE RELEASE June 15, 2015 Ovarian Cancer National Alliance honored for advocacy work OCNA called “leading advocacy organization for women impacted by ovarian cancer” WASHINGTON, DC — On Saturday, June 20, the Ovarian Cancer National Alliance (OCNA) will be honored by Facing Our Risk of Cancer Empowered (FORCE) at the 2015 Spirit of Empowerment … Continued
"Ovarian cancer is difficult to detect early -- there is no simple and reliable way to screen for it and symptoms are often not clear until later stages. By recognizing possible warning signs and unexplained changes, women can increase their likelihood of detecting ovarian cancer in its early stages when treatment is most effective and the chances for recovery are greatest. To bolster these efforts, my Administration has continued to invest in innovative research to improve early detection and treatment of ovarian cancer, and we are working hard to increase public awareness among women about all types of gynecological cancers." -President Barack Obama To read more, click the plus sign.
Get email updates about research news, action alerts, and ways to join the fight.
